Table 2.
Examples of hyperpolarized NMR probing.
| Observable | Probe | References |
|---|---|---|
| (i) Designed probes | ||
|
| ||
| Amino acid concentrations | acetic anhydride | [39] |
|
| ||
| Binding | 1H, 13C and 19F in binders | [42–44] |
|
| ||
| Drug metabolism | Carbamazepine | [46] |
|
| ||
| Ca2+ concentration | trimethylphenylammonium ubstituted with triacetic acid |
[38] |
|
| ||
| Contrast agent | 6LiCl | [63] |
|
| ||
| Enzyme activity | trimethylphenylammonium substituted with methyl ester |
[38] |
|
| ||
| Hocl | p-Anisidine | [36] |
|
| ||
| Hydrogen peroxide | benzoylformic acid trimethylphenylammonium substituted with boronic acid ester |
[38,64] |
|
| ||
| pH | 89Y-complexes | [28,34] |
|
| ||
| Protein expression | N-acetyl-L-methionine | [49] |
|
| ||
| (ii) Derivatized endogenous probes | ||
|
| ||
| Enzyme activity | 3,5-Difluorobenzoyl-L-glutamic acid (carboxypeptidase prodrug) |
[48] |
|
| ||
| Enzyme activity | ethyl pyruvate | [57] |
|
| ||
| Perfusion | permethylated amino acids (betains) | [51] |
|
| ||
| Protein expression | pyruvate derivatives as reporter groups | [37] |
|
| ||
| (iii) Endogenous probes | ||
|
| ||
| Cell permeability, lysis | fumarate metabolism | [65] |
| pyruvate diffusion | [66] | |
|
| ||
| Drug efficacy | pyruvate | [67–69] |
| fumarate | [65] | |
|
| ||
| Enzyme activities and reaction fluxes | ||
| • Ldh | pyruvate, lactate | [70,71] |
| • Alt | alanine, pyruvate | [50] |
| • Bcat | ketoisocaproic acid | [72] |
| • Glutaminase | glutamine | [73,74] |
| • Carnitine acetyltransferase, AcetylCoA synthetase |
acetate | [75] |
| • Betaine aldehyde metabolism | choline analog | [76] |
| • Pyruvate decarboxylase | pyruvate | [77] |
| • Pyruvate dehydrogenase | pyruvate | [78,79] |
|
| ||
| Enzyme mechanistic studies | fructose | [61] |
| alanine | [80] | |
|
| ||
| Gene expression, gene loss | glucose | [61,81] |
|
| ||
| Intracellular pH | acetate | [82] |
| pyruvate | [83] | |
|
| ||
| Metabolic strategies in different genomes | glucose | [61] |
|
| ||
| Oncogene signalling | pyruvate | [84] |
| ketoisocaproic acid | [72] | |
|
| ||
| Pathway activity, bottlenecks | ||
| • Glycolysis | glucose | [61,85–87] |
| • Indicator of aerobic glycolysis | [1-13C]pyruvate | [71,88,89] |
| • TCA cycle | [2-13C]pyruvate | [90] |
| • Fatty acid and ketone body metabolism | butyrate | [91] |
|
| ||
| Redox status | dehydroascorbic acid | [92,93] |
|
| ||
| Sulfite cytotoxicity | glucose | [94] |
|
| ||
| Tissue pH | bicarbonate | [95] |
|
| ||
| Transporter level and activity | ||
| •Glucose transporter | glucose | [86] |
| •Monocarboxylate transporter | pyruvate | [88,96] |
| •Urea carrier | urea | [97] |
|
| ||
| Tumor grading | alanine, pyruvate, lactate | [98] |